Skeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemia

References

• Kaste SC, Rai SN, Fleming K, et al. Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2006;46:77–87.
   PubMed Web of Science ®Google Scholar
• Le Meignen M, Auquier P, Barlogis V, et al. Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities. Blood 2011;118:1481–1489.
   PubMed Web of Science ®Google Scholar
• Makitie O, Heikkinen R, Toiviainen-Salo S, et al. Long-term skeletal consequences of childhood acute lymphoblastic leukemia in adult males: a cohort study. Eur J Endocrinol 2013;168:281–288.
   PubMed Web of Science ®Google Scholar
• Mandel K, Atkinson S, Barr RD, et al. Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol 2004;22: 1215–1221.
   PubMed Web of Science ®Google Scholar
• Maniadaki I, Stiakaki E, Germanakis I, et al. Evaluation of bone mineral density at different phases of therapy of childhood all. Pediatr Hematol Oncol 2006;23:11–18.
   PubMed Web of Science ®Google Scholar
• Janiszewski PM, Oeffinger KC, Church TS, et al. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab 2007;92:3816–3821.
   PubMed Web of Science ®Google Scholar
• Ness KK, Baker KS, Dengel DR, et al. Body composition, muscle strength deficits and mobility limitations in adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007;49: 975–981.
   PubMed Web of Science ®Google Scholar
• Harila-Saari AH, Huuskonen UE, Tolonen U, et al. Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials. Med Pediatr Oncol 2001;36:345–351.
   PubMedGoogle Scholar
• Lehtinen SS, Huuskonen UE, Harila-Saari AH, et al. Motor nervous system impairment persists in long-term survivors of childhood acute lymphoblastic leukemia. Cancer 2002;94:2466–2473.
   PubMed Web of Science ®Google Scholar
• Ramchandren S, Leonard M, Mody RJ, et al. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst 2009;14:184–189.
   PubMed Web of Science ®Google Scholar
• Bar G, Black PC, Gutjahr P, et al. Recovery kinetics of heart rate and oxygen uptake in long-term survivors of acute leukemia in childhood. Eur J Pediatr 2007;166:1135–1142.
   PubMed Web of Science ®Google Scholar
• Jarvela LS, Niinikoski H, Lahteenmaki PM, et al. Physical activity and fitness in adolescent and young adult long-term survivors of childhood acute lymphoblastic leukaemia. J Cancer Surviv 2010; 4:339–345.
   PubMed Web of Science ®Google Scholar
• Tonorezos ES, Snell PG, Moskowitz CS, et al. Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2013;60:1358–1364.
   PubMed Web of Science ®Google Scholar
• van Brussel M, Takken T, van der Net J, et al. Physical function and fitness in long-term survivors of childhood leukaemia. Pediatr Rehabil 2006;9:267–274.
   PubMedGoogle Scholar
• Warner JT, Bell W, Webb DK, et al. Daily energy expenditure and physical activity in survivors of childhood malignancy. Pediatr Res 1998;43:607–613.
   PubMed Web of Science ®Google Scholar
• Jarfelt M, Fors H, Lannering B, et al. Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia. Eur J Endocrinol 2006;154:303–309.
   PubMed Web of Science ®Google Scholar
• Joyce ED, Nolan VG, Ness KK, et al. Association of muscle strength and bone mineral density in adult survivors of childhood acute lymphoblastic leukemia. Arch Phys Med Rehabil 2011;92: 873–879.
   PubMed Web of Science ®Google Scholar
• Tillmann V, Darlington AS, Eiser C, et al. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia. J Bone Miner Res 2002;17:1073–1080.
   PubMed Web of Science ®Google Scholar
• Alos N, Grant RM, Ramsay T, et al. High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. J Clin Oncol 2012;30:2760–2767.
   PubMed Web of Science ®Google Scholar
• Diessel E, Fuerst T, Njeh CF, et al. Evaluation of a new body composition phantom for quality control and cross calibration of DXA devices. J Appl Physiol 2000;89:599–605.
   PubMed Web of Science ®Google Scholar
• Kalender WA. A phantom for standardization and quality control in spinal bone mineral measurements by QCT and DXA: design considerations and specifications. Med Phys 1992;19:583–586.
   PubMed Web of Science ®Google Scholar
• Kalender WA, Felsenberg D, Genant HK, et al. The European Spine Phantom - a tool for standardization and quality control in spinal bone mineral measurements by DXA and QCT. Eur J Radiol 1995;20:83–92.
   PubMed Web of Science ®Google Scholar
• Molgaard C, Thomsen BL, Prentice A, et al. Whole body bone mineral content in healthy children and adolescents. Arch Dis Child 1997;76:9–15.
   PubMed Web of Science ®Google Scholar
• Orwoll ES, Oviatt SK, Biddle JA. Precision of dual-energy x-ray absorptiometry: development of quality control rules and their application in longitudinal studies. J Bone Miner Res 1993;8: 693–699.
   PubMed Web of Science ®Google Scholar
• Zemel BS, Leonard MB, Kelly A, et al. Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 2010;95: 1265–1273.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. A SAS program for the CDC growth charts. Atlanta, GA: CDC; 26 March 2014. Available from: http://www.cdc.gov/nccdphp/dnpao/growthcharts/resources/sas.htm
   Google Scholar
• Marchese VG, Chiarello LA, Lange BJ. Effects of physical therapy intervention for children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2004;42:127–133.
   PubMed Web of Science ®Google Scholar
• Soucie JM, Wang C, Forsyth A, et al. Range of motion measurements: reference values and a database for comparison studies. Haemophilia 2011;17:500–507.
   PubMed Web of Science ®Google Scholar
• Eek MN, Kroksmark AK, Beckung E. Isometric muscle torque in children 5 to 15 years of age: normative data. Arch Phys Med Rehabil 2006;87:1091–1099.
   PubMed Web of Science ®Google Scholar
• Merlini L, Mazzone ES, Solari A, et al. Reliability of hand-held dynamometry in spinal muscular atrophy. Muscle Nerve 2002;26: 64–70.
   PubMed Web of Science ®Google Scholar
• Hager-Ross C, Rosblad B. Norms for grip strength in children aged 4-16 years. Acta Paediatr 2002;91:617–625.
   PubMed Web of Science ®Google Scholar
• Mathiowetz V, Wiemer DM, Federman SM. Grip and pinch strength: norms for 6- to 19-year olds. Am J Occup Ther 1986;40: 705–711.
   PubMed Web of Science ®Google Scholar
• Bruininks RH, Bruininks BD. BOT2 Bruininks-Oseretsky Test of Motor Proficiency. Circle Pines, MN: AGS Publishing; 2005.
   Google Scholar
• Geiger R, Strasak A, Treml B, et al. Six-minute walk test in children and adolescents. J Pediatr 2007;150:395–399.
   PubMed Web of Science ®Google Scholar
• Russell KM, Hudson M, Long A, et al. Assessment of health-related quality of life in children with cancer: consistency and agreement between parent and child reports. Cancer 2006;106: 2267–2274.
   PubMed Web of Science ®Google Scholar
• Landgraf JM, Abetz L, Ware JE. Child Health Questionnaire (CHQ): a user's manual. Boston, MA: HealthAct; 1999.
   Google Scholar
• Halton JM, Atkinson SA, Fraher L, et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 1996;11:1774–1783.
   PubMed Web of Science ®Google Scholar
• Rayar MS, Nayiager T, Webber CE, et al. Predictors of bony morbidity in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2012;59:77–82.
   PubMed Web of Science ®Google Scholar
• Riccio I, Marcarelli M, Del Regno N, et al. Musculoskeletal problems in pediatric acute leukemia. J Pediatr Orthop B 2013;22: 264–269.
   PubMed Web of Science ®Google Scholar
• van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, et al. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 2002;141:204–210.
   PubMed Web of Science ®Google Scholar
• Swiatkiewicz V, Wysocki M, Odrowaz-Sypniewska G, et al. Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia. Med Pediatr Oncol 2003;41:578–580.
   PubMedGoogle Scholar
• Halton J, Gaboury I, Grant R, et al. Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res 2009;24:1326–1334.
   PubMed Web of Science ®Google Scholar
• Atkinson SA, Halton JM, Bradley C, et al. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int J Cancer Suppl 1998; 11:35–39.
   PubMedGoogle Scholar
• Aldhafiri FK, McColl JH, Reilly JJ. Prevalence of being underweight and overweight and obesity at diagnosis in UK patients with childhood acute lymphoblastic leukaemia 1985-2002. J Hum Nutr Diet 2014;27:76–79.
   Google Scholar
• Esbenshade AJ, Simmons JH, Koyama T, et al. Body mass index and blood pressure changes over the course of treatment of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2011;56: 372–378.
   PubMed Web of Science ®Google Scholar
• Ruiz JC, Mandel C, Garabedian M. Influence of spontaneous calcium intake and physical exercise on the vertebral and femoral bone mineral density of children and adolescents. J Bone Miner Res 1995;10:675–682.
   PubMed Web of Science ®Google Scholar
• Au LE, Rogers GT, Harris SS, et al. Associations of vitamin D intake with 25-hydroxyvitamin D in overweight and racially/ethnically diverse US children. J Acad Nutr Diet 2013;113:1511–1516.
   Web of Science ®Google Scholar
• Ness KK, Hudson MM, Pui CH, et al. Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses. Cancer 2012;118:828–838.
   PubMed Web of Science ®Google Scholar
• Tan SY, Poh BK, Nadrah MH, et al. Nutritional status and dietary intake of children with acute leukaemia during induction or consolidation chemotherapy. J Hum Nutr Diet 2013.
   Web of Science ®Google Scholar
• Chow EJ, Pihoker C, Hunt K, et al. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia. Cancer 2007;110:2313–2320.
   PubMed Web of Science ®Google Scholar
• Chow EJ, Pihoker C, Friedman DL, et al. Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2013;60:621–626.
   PubMed Web of Science ®Google Scholar
• Orgel E, Sposto R, Malvar J, et al. Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group. J Clin Oncol 2014;32:1331–1337.
   PubMed Web of Science ®Google Scholar
• Gurney JG, Ness KK, Sibley SD, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 2006;107:1303–1312.
   PubMed Web of Science ®Google Scholar
• Oeffinger KC, Adams-Huet B, Victor RG, et al. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 2009;27: 3698–3704.
   PubMed Web of Science ®Google Scholar
• Steinberger J, Sinaiko AR, Kelly AS, et al. Cardiovascular risk and insulin resistance in childhood cancer survivors. J Pediatr 2012;160:494–499.
   PubMed Web of Science ®Google Scholar
• Tonorezos ES, Vega GL, Sklar CA, et al. Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatr Blood Cancer 2012;58:31–36.
   PubMed Web of Science ®Google Scholar
• Rayar M, Webber CE, Nayiager T, et al. Sarcopenia in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2013; 35:98–102.
   PubMed Web of Science ®Google Scholar
• Kameda G, Vieker S, Duck C, et al. Paraneoplastic myopathy as a very rare manifestation of acute lymphoblastic leukemia. Klin Padiatr 2010;222:386–387.
   PubMed Web of Science ®Google Scholar
• Gocha Marchese V, Chiarello LA, Lange BJ. Strength and functional mobility in children with acute lymphoblastic leukemia. Med Pediatr Oncol 2003;40:230–232.
   PubMedGoogle Scholar
• Bindels LB, Beck R, Schakman O, et al. Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. PLoS One 2012;7:e37971.
   PubMed Web of Science ®Google Scholar
• Menconi M, Fareed M, O’Neal P, et al. Role of glucocorticoids in the molecular regulation of muscle wasting. Crit Care Med 2007;35:S602–608.
   Web of Science ®Google Scholar